Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient.
bla KPC -3
cross-resistance
imipenem/relebactam
meropenem/vaborbactam
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
05 Apr 2022
05 Apr 2022
Historique:
received:
10
03
2022
revised:
03
04
2022
accepted:
04
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Novel carbapenem-β-lactamase inhibitor combination,
Identifiants
pubmed: 35456827
pii: microorganisms10040778
doi: 10.3390/microorganisms10040778
pmc: PMC9025179
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministero della Salute
ID : GR-2018-12367572
Références
Clin Microbiol Rev. 2018 Feb 14;31(2):
pubmed: 29444952
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28320716
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W347-52
pubmed: 21672955
Antibiotics (Basel). 2021 May 06;10(5):
pubmed: 34066420
Clin Microbiol Infect. 2022 Feb 3;:
pubmed: 35124257
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1143-1150
pubmed: 30825054
Clin Infect Dis. 2020 Apr 15;70(9):1799-1808
pubmed: 31400759
Int J Infect Dis. 2021 Dec;113:213-217
pubmed: 34656787
J Antimicrob Chemother. 2018 Jun 1;73(6):1525-1529
pubmed: 29566151
AIMS Microbiol. 2018 Jun 26;4(3):482-501
pubmed: 31294229
J Glob Antimicrob Resist. 2020 Jun;21:86-90
pubmed: 31639545
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31332070
J Antimicrob Chemother. 2022 Apr 01;:
pubmed: 35373297
Clin Microbiol Infect. 2020 Apr;26(4):516.e1-516.e4
pubmed: 31740422
J Antimicrob Chemother. 2018 Jul 1;73(7):1872-1879
pubmed: 29659861
Viruses. 2021 Oct 20;13(11):
pubmed: 34834917
Microb Drug Resist. 2018 Sep;24(7):877-881
pubmed: 29782237
Antimicrob Agents Chemother. 2020 Dec 16;65(1):
pubmed: 33106265
Pharmacotherapy. 2020 Apr;40(4):343-356
pubmed: 32060929